Edema is an important target for clinical intervention after traumatic brain injury (TBI). We used in vivo cellular resolution imaging and electrophysiological recording to examine the ionic mechanisms underlying neuronal edema and their effects on neuronal and network excitability after controlled cortical impact (CCI) in mice. Unexpectedly, we found that neuronal edema 48 hours after CCI was associated with reduced cellular and network excitability, concurrent with an increase in the expression ratio of the cation-chloride cotransporters (CCCs) NKCC1 and KCC2. Treatment with the CCC blocker bumetanide prevented neuronal swelling via a reversal in the NKCC1/KCC2 expression ratio, identifying altered chloride flux as the mechanism of neuronal edema. Importantly, bumetanide treatment was associated with increased neuronal and network excitability after injury, including increased susceptibility to spreading depolarizations (SDs) and seizures, known agents of clinical worsening after TBI. Treatment with mannitol, a first-line edema treatment in clinical practice, was also associated with increased susceptibility to SDs and seizures after CCI, showing that neuronal volume reduction, regardless of mechanism, was associated with an excitability increase. Finally, we observed an increase in excitability when neuronal edema normalized by 1 week after CCI. We conclude that neuronal swelling may exert protective effects against damaging excitability in the aftermath of TBI and that treatment of edema has the potential to reverse these effects.
Punam A. Sawant-Pokam, Tyler J. Vail, Cameron S. Metcalf, Jamie L. Maguire, Thomas O. McKean, Nick O. McKean, K.C. Brennan
Title and authors | Publication | Year |
---|---|---|
Uncovering novel KCC2 regulatory motifs through a comprehensive transposon-based mutant library
Uvarov P, Fudo S, Karakus C, Golubtsov A, Rotondo F, Sukhanova T, Soni S, Di Scala C, Kajander T, Rivera C, Ludwig A |
Frontiers in Molecular Neuroscience | 2025 |
Imaging the large-scale and cellular cortical response to focal traumatic brain injury in mouse neocortex
Bibineyshvili Y, Vajtay TJ, Salsabilian S, Fliss N, Suvarnakar A, Fang J, Teng S, Alder J, Najafizadeh L, Margolis DJ |
2024 | |
Spreading Depolarization Induces a Transient Potentiation of Excitatory Synaptic Transmission
Weisend JE, Carlson AP, Shuttleworth CW |
Neuroscience | 2024 |
The SWELL1 Channel Promotes Ischemic Brain Damage by Mediating Neuronal Swelling and Glutamate Toxicity
Chen J, Yang J, Chu J, Chen KH, Alt J, Rais R, Qiu Z |
Advanced Science | 2024 |
Imaging the large‐scale and cellular response to focal traumatic brain injury in mouse neocortex
Bibineyshvili Y, Vajtay TJ, Salsabilian S, Fliss N, Suvarnakar A, Fang J, Teng S, Alder J, Najafizadeh L, Margolis DJ |
Experimental Physiology | 2024 |
Role of NKCC1 and KCC2 during hypoxia-induced neuronal swelling in the neonatal neocortex
Takezawa Y, Langton R, Baule SM, Zimmerman MB, Baek S, Glykys J |
Neurobiology of Disease | 2023 |
AQP4 Aggravates Cognitive Impairment in Sepsis‐Associated Encephalopathy through Inhibiting Nav1.6‐Mediated Astrocyte Autophagy
Zhu D, Huang Y, Guo S, Li N, Yang X, Sui A, Wu Q, Zhang Y, Kong Y, Li Q, Zhang T, Zheng W, Li A, Yu J, Ma T, Li S |
Advanced Science | 2023 |
Bumetanide Attenuates Cognitive Deficits and Brain Damage in Rats Subjected to Hypoxia-Ischemia at Two Time Points of the Early Postnatal Period.
Machado DN, Durán-Carabali LE, Odorcyk FK, Carvalho AVS, Martini APR, Schlemmer LM, de Mattos MM, Bernd GP, Dalmaz C, Netto CA |
Neurotoxicity Research | 2023 |
Dexamethasone-Enhanced Continuous Online Microdialysis for Neuromonitoring of O2 after Brain Injury
Robbins EM, Jaquins-Gerstl AS, Okonkwo DO, Boutelle MG, Michael AC |
ACS Chemical Neuroscience | 2023 |
Co-administration of Nanowired Oxiracetam and Neprilysin with Monoclonal Antibodies to Amyloid Beta Peptide and p-Tau Thwarted Exacerbation of Brain Pathology in Concussive Head Injury at Hot Environment.
Nozari A, Sharma A, Wang Z, Feng L, Muresanu DF, Tian ZR, Lafuente JV, Buzoianu AD, Wiklund L, Sharma HS |
Advances in Neurobiology | 2023 |
Evaluation of bumetanide as a potential therapeutic agent for Alzheimer’s disease
Boyarko B, Podvin S, Greenberg B, Momper JD, Huang Y, Gerwick WH, Bang AG, Quinti L, Griciuc A, Kim DY, Tanzi RE, Feldman HH, Hook V |
Frontiers in pharmacology | 2023 |
Alpha-methyltyrosine reduces the acute cardiovascular and behavioral sequelae in a murine model of traumatic brain injury
Woodman R, Miller C, Student J, Freeman K, Perl D, Lockette W |
The journal of trauma and acute care surgery | 2023 |
Deferoxamine Induces Autophagy Following Traumatic Brain Injury via TREM2 on Microglia.
Zhang C, Xu C, Jing Y, Cao H, Wang X, Zhao J, Gong Q, Chen S |
Molecular Neurobiology | 2023 |
Spreading Depolarizations Contribute to the Acute Behavior Deficits Associated With a Mild Traumatic Brain Injury in Mice.
Pinkowski NJ, Fish B, Mehos CJ, Carlson VL, Hess BR, Mayer AR, Morton RA |
Journal of Neurotrauma | 2023 |
Neonatal hyperoxia in mice impairs cerebrovascular function, neurogenesis, and behavior into adulthood
Marissa A. Lithopoulos, Xavier Toussay, Shumei Zhong, Liqun Xu, Shamimunisa B. Mustafa, Julie Ouellette, Cesar C. Comin, Hayam Bassam, Adam Baker, Michael Wakem, Alvaro G Moreira, Cynthia Blanco, Arul Vadivel, Catherine Tsilfidis, Steven Seidner, Ruth S. Slack, Diane C Lagace, Jing Wang, Baptiste Lacoste, Bernard Thébaud |
Journal of Clinical Investigation | 2022 |
Silencing KCC2 in mouse dorsal hippocampus compromises spatial and contextual memory.
Simonnet C, Sinha M, Goutierre M, Moutkine I, Daumas S, Poncer JC |
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology | 2022 |
Neuronal Swelling: A Non-osmotic Consequence of Spreading Depolarization
JA Hellas, RD Andrew |
Neurocritical Care | 2021 |
Microenvironmental Variations After Blood-Brain Barrier Breakdown in Traumatic Brain Injury
Y Hu, W Tao |
Frontiers in molecular neuroscience | 2021 |